High proportion of nontypeable streptococcus pneumoniae isolates among sporadic, nonoutbreak cases of bacterial conjunctivitis

Current Eye Research

Volumn 36, Issue 12, 2011, Pages 1078-1085

  Haas, Wolfgang ^a   Hesje, Christine K ^a   Sanfilippo, Christine M ^a   Morris, Timothy W ^a  

^a BAUSCH AND LOMB   (United States)

Author keywords

Antibiotic resistance; Bacterial conjunctivitis; Capsule; Streptococcus pneumoniae; Vaccine strains

Indexed keywords

AZITHROMYCIN; BESIFLOXACIN; CARBAPENEM; CEFTRIAXONE; CEPHEM; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINCOSAMIDE; LINEZOLID; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLONE DERIVATIVE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL CONJUNCTIVITIS; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BROTH DILUTION; CHILD; CONJUNCTIVITIS; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; OPERON; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CONJUNCTIVA; CONJUNCTIVITIS, BACTERIAL; DISEASE OUTBREAKS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PROGNOSIS; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; YOUNG ADULT;

EID: 81255142794     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.624670     Document Type: Article

References (35)

1. Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010;16:217-225.
2. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008;6:288-301.
3. Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 2007;26:123-128.
4. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007;82:93-104.
5. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR Morb Mortal Wkly Rep 2010;59:253-257.
6. Pilishvili T, Lexau C, Farley MM et al.; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32-41.
7. Mera RM, Miller LA, Amrine-Madsen H, Sahm DF. The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the United States since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics. Microb Drug Resist 2009;15:261-268.
8. Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J 2005;24:823-828.
9. Gigliotti F, Williams WT, Hayden FG et al. Etiology of acute conjunctivitis in children. J Pediatr 1981;98:531-536.
10. Mueller JB, McStay CM. Ocular infection and inflammation. Emerg Med Clin North Am 2008;26:57-72, vi.
11. Reed JM, O'Callaghan RJ, Girgis DO, McCormick CC, Caballero AR, Marquart ME. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model. Invest Ophthalmol Vis Sci 2005;46:604-608.
12. Shayegani M, Parsons LM, Gibbons WE Jr, Campbell D. Characterization of nontypable Streptococcus pneumoniaelike organisms isolated from outbreaks of conjunctivitis. J Clin Microbiol 1982;16:8-14.
13. Nunes S, Sa-Leao R, Carrico J et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumonia colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol 2005;43:1285-1293.
14. Rodrigues F, Nunes S, Sa-Leao R, Goncalves G, Lemos L, de Lencastre H. Streptococcus pneumoniae nasopharyngeal carriage in children attending day-care centers in the central region of Portugal, in the era of 7-valent pneumococcal conjugate vaccine. Microb Drug Resist 2009;15:269-277.
15. Lopez B, Cima MD, Vazquez F et al. Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children. Eur J Clin Microbiol Infect Dis 1999;18:771-776.
16. Crum NF, Barrozo CP, Chapman FA, Ryan MA, Russell KL. An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees. Clin Infect Dis 2004;39:1148-1154.
17. Martin M, Turco JH, Zegans ME et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med 2003;348:1112-1121.
18. Karpecki P, Depaolis M, Hunter JA et al. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. Clin Ther 2009;31:514-526.
19. Tepedino ME, Heller WH, Usner DW et al. Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis. Curr Med Res Opin 2009;25:1159-1169.
20. McDonald MB, Protzko EE, Brunner LS et al. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. Ophthalmology 2009;116:1615-1623.e1.
21. Slotved HC, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F. Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex). J Clin Microbiol 2004;42:2518-2522.
22. Kong F, Gilbert GL. Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes. J Med Microbiol 2003;52:1047-1058.
23. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, Eighth Edition. CLSI document M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA, 2009.
24. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth Informational Supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA, 2010.
25. Arbique JC, Poyart C, Trieu-Cuot P et al. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol 2004;42:4686-4696.
26. Carvalho MG, Steigerwalt AG, Thompson T, Jackson D, Facklam RR. Confirmation of nontypeable Streptococcus pneumoniae-like organisms isolated from outbreaks of epidemic conjunctivitis as Streptococcus pneumoniae. J Clin Microbiol 2003;41:4415-4417.
27. Hanage WP, Kaijalainen T, Saukkoriipi A, Rickcord JL, Spratt BG. A successful, diverse disease-associated lineage of nontypeable pneumococci that has lost the capsular biosynthesis locus. J Clin Microbiol 2006;44:743-749.
28. Pearce BJ, Iannelli F, Pozzi G. Construction of new unencapsulated (rough) strains of Streptococcus pneumoniae. Res Microbiol 2002;153:243-247.
29. Lysenko ES, Lijek RS, Brown SP, Weiser JN. Within-host competition drives selection for the capsule virulence determinant of Streptococcus pneumoniae. Curr Biol 2010;20:1222-1226.
30. Haas W, Pillar CM, Torres M et al. Monitoring antibiotic resistance in ocular microorganisms - results from the ARMOR 2009 surveillance study. Am J Ophthalmol 2011;152:567-574.
31. Asbell PA, Colby KA, Deng S et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol 2008;145:951-958.
32. Johnson DM, Stilwell MG, Fritsche TR, Jones RN. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999- 2003). Diagn Microbiol Infect Dis 2006;56:69-74.
33. Pletz MW, McGee L, Jorgensen J et al. Levofloxacinresistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 2004;48:3491-3497.
34. Mera RM, Miller LA, Amrine-Madsen H, Sahm DF. Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time. Microb Drug Resist 2011;17:47-52.
35. Porat N, Greenberg D, Givon-Lavi N et al. The important role of nontypable Streptococcus pneumoniae international clones in acute conjunctivitis. J Infect Dis 2006;194:689-696.